Alternative splicing in lung cancer
Palabras clave : 
Alternative splicing
Lung cancer
Bcl-x, CD44
RNA binding protein
hnRNP
Fecha de publicación: 
4-jun-2009
Editorial : 
Lippincott, Williams & Wilkins
ISSN: 
1556-0864
Cita: 
Pio R, Montuenga LM. Alternative splicing in lung cancer. J Thorac Oncol 2009 Jun;4(6):674-678.
Resumen
Abstract: Alterations in alternative splicing affect essential biologic processes and are the basis for a number of pathologic conditions, including cancer. In this review we will summarize the evidence supporting the relevance of alternative splicing in lung cancer. An example that illustrates this relevance is the altered balance between Bcl-xL and Bcl-xS, two splice variants of the apoptosis regulator Bcl-x. Splice modifications in cancer-related genes can be associated with modifications either in cis-acting splicing regulatory sequences or in trans-acting splicing factors. In fact, lung tumors show abnormal expression of splicing regulators such as ASF/SF2 or some members of the heterogeneous nuclear ribonucleoprotein family. The potential significance of alternative splicing as a target for lung cancer diagnosis or treatment will also be discussed.

Ficheros en este registro:
Fichero: 
Alternative_Splicing_in_Lung_Cancer.2.pdf
Descripción: 
Tamaño: 
489,09 kB
Formato: 
Adobe PDF


Los ítems de Dadun están protegidos por copyright, con todos los derechos reservados, a menos que se indique lo contrario.